Research Training Group
genes, environment, inflammation
Within this Research Training Group we will study the environmental influences responsible for the development of complex, chronic diseases. Moreover, we will systematically examine the previously understudied interplay between the (micro)-environment and predisposing genetic factors...
The scientists in the Research Training Group (RTG) want to find out
- how the non-genetical schemes in the cell change during the development of chronic inflammatory diseases;
- how diet influences the development of inflammatory diseases;
- new statistical and bioinformatical ways to express research results.
a team of young and innovative scientists who are experts in the fields of:
- molecular biology
- human genetics
The purpose of the structured doctoral student programme is to:
- enable young scientists to obtain their doctoral degree within three years;
- qualify doctoral students for postdoctoral work;
- impart interdisciplinary knowledge;
- promote postgraduate students' transferrable skills.
Funding obtained by the ‘Bundesministerium für Bildung und Forschung’ (BMBF): Two projects of an interdisciplinary research consortium “MESINFLAME” are performed at the Department of Rheumatology and Clinical Immunology “Integrative preclinical strategies for targeting the local mesenchyme as a regulator of tissue specificity in inflammatory musculoskeletal disorders (IMDs)" – this is the title of the interdisciplinary research consortium MESINFLAME, which is funded by the BMBF with a grant of 4 Mio. €.
Coordinated by Prof. Thomas Pap of the Institute for Experimental Musculoskeletal Medicine at the University of Münster, an interdisciplinary team of scientists from different clinical disciplines (rheumatology, neurology, dentistry, microbiology), basic research (immunology, anatomy, cartilage and bone biology) and a start-up company is investigating the role of connective tissue (mesenchyme) in the pathogenesis of inflammatory musculoskeletal disorders (IMDs). Furthermore, innovative diagnostic and therapeutic strategies will be evaluated.
Member of the Steering Committee is Prof. Gabriela Riemekasten , Director of the Department of Rheumatology and Clinical Immunology of the University Medical Center Schleswig-Holstein in Lübeck. She is Co-Supervisor in Project 6_2015 and _2018 of the RTG 1743. Together with Prof. Tanja Lange (UzL) and Prof. Xinhua Yu (Research Center Borstel) as well as colleagues from Heidelberg and the start-up company LysatPharma...